Crescent Bio Expands Its Cancer Drug Combo Ambitions With New Kelun-Biotech Alliance
One of the hotter areas of cancer drug research involves using a particular type of bispecific antibody as the backbone for therapeutic combinations intended to bring a multi-pronged attack to tumors. Crescent Biopharma has one such bispecific antibody in …